Munich, Germany

Bernd Adam

This inventor holds 1 USPTO granted patent. Top assignee: Lts Lohmann Therapie-Systeme Ag. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bernd Adam. Retrieved from https://idiyas.com/inventor/bernd-adam-tisl9oqz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Bernd Adam: Innovator in Transdermal Drug Delivery

Introduction

Bernd Adam is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medicine through his innovative approaches to drug delivery systems. His work focuses on enhancing the effectiveness of transdermal medication.

Latest Patents

One of Bernd Adam's key inventions is a device and method for increasing the transdermal permeation of medicaments. This invention is characterized by the administration of a constituent that effects a local increase in temperature and/or an increase in blood flow to the skin, in addition to the transdermally applied active substance. This innovative approach aims to improve the absorption and efficacy of medications delivered through the skin.

Career Highlights

Bernd Adam is associated with LTS Lohmann Therapie-Systeme AG, a company known for its advancements in transdermal drug delivery systems. His work at the company has been instrumental in developing new methods that enhance patient care and treatment outcomes.

Collaborations

Throughout his career, Bernd Adam has collaborated with notable colleagues, including Rudolf Matusch and Christian Von Falkenhausen. These collaborations have contributed to the advancement of innovative solutions in the field of transdermal drug delivery.

Conclusion

In summary, Bernd Adam is a pioneering inventor whose work in transdermal drug delivery has the potential to significantly impact the medical field. His innovative methods and collaborations continue to drive advancements in medication administration.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…